New York, NY -- NewYork Weill Cornell Medical Center of NewYork-Presbyterian Hospital is currently seeking patients for a nationwide, multicenter clinical research trial to explore the benefits of a unique vaccine to treat low-grade follicular non-Hodgkin's lymphoma (NHL). This randomized Phase 3 study will test a personalized immunotherapy vaccine created from a patient's own tumor cells to potentially combat the cancer and interfere with disease progression. NewYork Weill Cornell is the only site in New York State participating in this trial. "This study is for patients with previously untreated, advanced stage low-grade non-Hodgkin's lymphoma who want to use their own immune system as a first line of defense to fight the disease," said John P. Leonard, M.D., Assistant Professor of Medicine, Medical Director, Oncology Services, Weill Cornell Medical College of Cornell University, and investigator on the trial. "Low-grade NHL is a cancer with no readily available cure, and conventional treatments such as chemotherapy and radiation have been shown to lose efficacy and cause side effects as the disease progresses. We are hopeful that this technique for stimulating the immune system to recognize and then attack the cancer will result in longer-term remissions."
The Cornell Faculty Institute for Diversity, held June 7-10 at the ILR Conference Center, helped 19 Cornell professors navigate the sometimes complex territory of diversity. (June 17, 2009)
Alyssa Apsel envisions next-generation circuits to have shrunk to the most infinitesimal of length scales, but with higher efficiency and more predictable properties. (Aug. 6, 2008)
The 2001-02 Cornell Tradition Student Advisory Council has announced the creation of a new Cornell Tradition Community Recognition Award to be offered this year for the first time to honor and recognize an Ithaca-area community member who embodies the ideals of the Cornell Tradition: commitment to community service, strong work ethic and scholarship.
Cornell animal science researchers will begin researching the effects of the newly discovered hormone, thanks to a three-year, $350,000 grant from the USDA. (May 12, 2010)
New virulent types of the potato late blight pathogen have emerged in Russia, threatening farmers and consumers with the destruction of an essential staple crop there, according to the Cornell-Eastern Europe-Mexico (CEEM) Potato Late Blight Program.
In his Applied Ergonomics class, Professor Alan Hedge worked with his students to create CUErgopods -- audio and video podcasts that bring the latest research on ergonomics for computer users into the real world setting of student life on campus.
Cornell researchers have made nanoresonators with a record high quality factor, or 'Q,' that can detect minute changes in mass or gas pressure. (Feb. 13, 2008)
Events this week include Jason and Alicia Hall Moran in Barnes Hall; 'Chasing Ice' at Cornell Cinema, a community project with artists and survivors of assault, and the American Indian Program's 30th anniversary conference.